네오이뮨텍 사업보고서 (2025.12)
주요 지적 재산권

☞ 본문 위치로 이동

번호	구분	내용	권리자	출원일	등록일	적용 제품

1	특허권	Use of interleukin 7 and chimeric antigen receptor (CAR) bearing immune effector cells for treating tumor	당사/Washington Univ.	2018-07-31 등 2건 (가출원)
2019-07-30 (PCT)2021-01-29 (미국)2021-02-24 (유럽)2021-01-20 (캐나다)	-	NT-I7

2	특허권	Method of Treating a Tumor with a Combination of IL-7 Protein and an Immune Checkpoint Inhibitor	당사/주식회사 제넥신	2018-11-16 등 3건 (가출원)
2019-11-15 (PCT)2021-06-14 (한국)2021-05-14 (미국)2021-03-26 (유럽)2021-05-07 (캐나다) 2021-06-22 (중국)2021-05-10 (호주)2021-06-16 (일본)2024-08-23 (일본-분할)2021-12-31 (홍콩)2021-05-16 (뉴질랜드)2021-12-17 (인도)2021-06-14 (인도네시아)	-	NT-I7

3	특허권	Method of treating a tumor with a combination of IL-7 protein and a bispecific antibody	당사	2020-01-13 등 3건 (가출원)
2021-01-12 (PCT)2022-07-01 (한국)2022-07-13 (미국)2022-08-03 (유럽)2022-06-30 (호주)2022-07-05 (캐나다)2022-07-12 (일본)2022-07-13 (중국)2022-07-11 (이스라엘)	-	NT-I7

4	특허권	Method of treating a solid tumor with a combination of IL-7 protein and CAR bearing immune cells	당사/Washington Univ.	2020-02-05 (가출원)2021-02-04 (PCT)2022-07-13 (한국)2022-08-05 (미국)2022-09-05 (유럽)2022-07-11 (호주)2022-07-26 (일본)	-	NT-I7

5	특허권	Method for increasing lymphocyte count by using IL.7 fusion	당사/주식회사 제넥신	2019-09-04 등 2건 (가출원)
2020-09-04 (PCT)2022-03-31 (한국)2022-02-25 (미국)2022-03-03 (유럽)2022-02-03 (캐나다)2022-02-21 (호주)2022-03-03 (일본)2022-03-02 (중국)2022-03-03 (이스라엘)2022-03-03 (태국)2022-03-29 (인도)2022-03-03 (아랍에미리트)2022-03-24 (인도네시아)2022-02-11 (싱가포르)2022-03-03 (사우디아라비아)2022-04-01 (남아프리카공화국)2022-01-31 (뉴질랜드)2022-02-23 (멕시코)2022-03-30 (러시아)2022-02-22 (브라질)2022-03-28 (베트남)
2025-07-25 (중국-분할)	2023-11-29 (남아프리카공화국)
2024-07-04 (러시아)2024-12-12 (호주)	NT-I7

6	특허권	Modified interleukin-7 protein and uses thereof	당사/주식회사 제넥신	2020-04-16 (한국)2020-04-16 (한국)2020-04-16 (한국)2021-04-16 (미국)	-	NT-I7

7	특허권	Modified Interleukin-7 Protein and Uses Thereof	주식회사 제넥신	2016-06-10 (PCT)2016-09-15 (미국)2018-06-05 (미국-분할1)2018-12-13 (미국-분할2)2018-01-03 (유럽)2017-11-17 (캐나다)2017-12-11 (브라질)2018-01-10 (러시아)	2019-02-19 (미국)2020-11-24 (미국-분할1)
2021-06-22 (미국-분할2) 2019-12-04 (러시아)
2024-02-27 (캐나다)	NT-I7

8	특허권	Formulation of modified interleukin-7 fusion protein	주식회사 제넥신	2016-11-02 (PCT)2018-03-05 (미국)2022-11-08 (미국-분할 1)2025-01-17 (미국-분할 2)	2023-01-10 (미국)2025-07-01 (미국-분할 1)	NT-I7

9	특허권	Pharmaceutical composition comprising immunoglobulin fc-fused interleukin-7 fusion protein for preventing or treating infection from influenza virus	주식회사 제넥신	2016-11-30 (PCT)2018-05-18 (미국)2022-06-13 (미국-분할)	2022-06-14 (미국)2025-07-15 (미국-분할)	NT-I7

10	특허권	Pharmaceutical composition comprising immunoglobulin fc-fused interleukin-7 fusion protein for preventing or treating human papillomavirus-caused diseases	주식회사 제넥신	2016-12-02 (PCT)
2018-11-08 (미국)
2023-06-01 (미국-분할 1)2025-01-17 (미국-분할 2)	2023-07-25 (미국)2025-11-25 (미국-분할 1)	NT-I7

11	특허권	Immunoglobulin fusion protein ("hyFc”) * 지속형 단백질 제조 플랫폼으로 IL-7에 한정하여 사용함	주식회사 제넥신	2008-05-30 (PCT)2008-05-30 (미국)2010-11-19 (미국-분할1)2008-05-30 (유럽)2008-05-30 (유럽-분할1)2008-05-30 (캐나다)2008-05-30 (브라질)2008-05-30 (러시아)	2011-01-11 (미국)2013-11-19 (미국-분할1)2013-02-27 (유럽)2017-02-15 (유럽-분할1)2013-05-14 (캐나다)2020-11-24 (브라질)2014-10-10 (러시아)	NT-I7

12	특허권	Novel Piperidine-2,6-Dione derivative and use thereof * 당사와 유빅스 테라퓨틱스가 합의한 3종 신규 타겟 프로탁에 한정하여 사용함	한국화학연구원 (KRICT)	2017-12-29 (한국)2018-05-11 (PCT)2019-08-20 (한국-분할1)2019-10-31 (미국)2019-10-28 (유럽)2019-11-06 (일본)2019-11-12 (중국)	2019-08-20 (한국)2021-12-07 (미국)2022-01-19 (유럽)
2022-10-20 (일본)
2023-08-01 (중국)	T cell Suppressor Blockade

13	특허권	Method of inducing stem cell mobilization	당사/주식회사 제넥신/포스텍 산학협력단	2021-10-25 (PCT)
2023-04-26 (미국)
2023-05-24 (유럽)
2023-05-09 (한국)	-	NT-I7

14	특허권	Use of Interleukin-7 for the treatment of coronavirus	당사	2021-11-02 (PCT)
2023-05-15 (한국)
2023-05-02 (미국)
2023-05-24 (유럽)	-	NT-I7

15	특허권	Method of treating a tumor with a combination of an IL-7 protein and a nucleotide vaccine	당사	2021-11-05 (PCT)
2023-05-15 (한국)
2023-05-04 (미국)
2023-06-05 (유럽)
2023-05-02 (일본)
2023-04-13 (캐나다)
2023-04-28 (호주)
2023-11-05 (중국)
2023-05-18 (인도)
2023-04-27 (이스라엘)	-	NT-I7

16	특허권	Method of treating a tumor with a combination of IL-7 protein and VEGF antagonist	당사/주식회사 제넥신	2022-12-30 (PCT)2024-07-04 (한국)
2024-06-28 (미국)
2024-07-29 (유럽)
2024-06-28 (일본)
2024-10-16 (중국)	-	NT-I7

17	특허권	Method of treating a tumor with an unmethylated MGMT promoter	당사/Washington Univ.	2023-11-07 (PCT)2025-03-26 (한국)2025-05-07 (미국)2025-06-05 (유럽)2025-05-02 (일본)2025-05-02 (캐나다)	-	NT-I7

18	특허권	Heterodimeric Fc Molecules And Uses Thereof	당사/포스텍 산학협력	2024-07-02 (PCT)	-	NT3020